Resources Repository
-
EditorialPublication 2020Waiting for Certainty on COVID-19 Antibody Tests — At What Cost?
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation …
This perspective anticipates the availability of serologic antibody testing and considers its potential usefulness in mitigation policy to reduce COVID-19 transmission. For example: Could we screen for serologic antibodies as a proxy for possible immunity and identify people who could return to the workplace with less severe mitigation measures? The authors acknowledge the uncertainties raised by many policy actors, including the WHO, such as, "Do antibodies confer immunity and, if so, for how long? How accurate is…
Test Performance | Probability/Bayes | Technology Assessment | Infectious Diseases | Health Systems | Policy/Regulation | Government/Law | Health/Medicine | Global | North America -
GuidelinesWeb Portal 2013Handbook for Diagnostic Test Accuracy
The Cochrane handbook for reviews of diagnostic test accuracy is produced by the Cochrane Diagnostic …
The Cochrane handbook for reviews of diagnostic test accuracy is produced by the Cochrane Diagnostic Test Accuracy Working Group. This group was constituted by the Steering Group of the Cochrane Collaboration to implement the publication of systematic reviews of diagnostic test accuracy within the Cochrane Collaboration. The handbook is structured as Part 1. Cochrane Reviews which contains four chapters and Part 2. General Methods for Cochrane Reviews of Diagnostic Test Accuracy which contains seven chapters. This web…
Test Performance | Evidence Synthesis | Health Systems | Health/Medicine | Global